Pro- and Antifibrotic Factors in the Serum of Patients with Chronic Myeloproliferative Disorders
Background. The study of pro- and antifibrotic factors in the serum of patients with Ph-negative chronic myeloproliferative disorders (CMPDs) will allow to understand better the mechanisms of myelofibrosis development, as well as to identify new diagnostic markers. Aim. To assess the correlation...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Practical Medicine Publishing House
2017-10-01
|
| Series: | Kliničeskaâ onkogematologiâ |
| Subjects: | |
| Online Access: | http://bloodjournal.ru/wp-content/uploads/2017/10/7_1.pdf |